Prostaglandin i2 analogs suppress tumor necrosis factor α production and the maturation of human monocyte-derived dendritic cells

Journal of Investigative Medicine

Volumn 59, Issue 7, 2011, Pages 1109-1115

  Yeh, Ching Hui ^a   Kuo, Chang Hung ^b,c,d   Yang, San Nan ^c,d   Huang, Ming Yii ^c,e   Wu, Hsaing Chi ^a   Wang, Hsing Pi ^b   Kuo, Thai Hung ^a   Hung, Chih Hsing ^b,c,d  

^a Zuoying Armed Force General Hospital   (Taiwan)

^b Department of Pediatrics   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d Graduate Institute of Medicine   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Monocyte derived dendritic cell; Tumor necrosis factor costimulatory molecule

Indexed keywords

1 ACETYL 2 (8 CHLORO 10,11 DIHYDRODIBENZ[B,F][1,4]OXAZEPINE 10 CARBONYL)HYDRAZINE; 6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; B7 ANTIGEN; CAY 10449; CD40 ANTIGEN; CD86 ANTIGEN; CYTOKINE; FORSKOLIN; GAMMA INTERFERON; GW 627368X; HLA DR ANTIGEN; ILOPROST; INTERLEUKIN 13; INTERLEUKIN 17; LIPOPOLYSACCHARIDE; PROSTACYCLIN DERIVATIVE; PROSTANOID RECEPTOR; PROSTANOID RECEPTOR ANTAGONIST; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNIPROST; BENZOPHENONE DERIVATIVE; CAY10449; CYCLIC AMP; DRUG DERIVATIVE; IMIDAZOLE DERIVATIVE; PROSTACYCLIN; PROSTAGLANDIN E RECEPTOR 1; PTGER1 PROTEIN, HUMAN; VASODILATOR AGENT;

ARTICLE; ASTHMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MONOCYTE; T LYMPHOCYTE; BIOSYNTHESIS; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; IMMUNE SYSTEM; METABOLISM; MONONUCLEAR CELL;

ASTHMA; BENZOPHENONES; CYCLIC AMP; DENDRITIC CELLS; EPOPROSTENOL; HUMANS; ILOPROST; IMIDAZOLES; IMMUNE SYSTEM; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MONOCYTES; RECEPTORS, PROSTAGLANDIN E, EP1 SUBTYPE; TUMOR NECROSIS FACTOR-ALPHA; VASODILATOR AGENTS;

EID: 85047689349     PISSN: 17088267     EISSN: 17088267     Source Type: Journal    
DOI: 10.2310/JIM.0b013e3182281f62     Document Type: Article

References (42)

1. Barnes PJ, Chung KF, Page CP. Inflammatory mediators of asthma: an update. Pharmacol Rev. 1998;50:515-596. (Pubitemid 29028812)
2. Ying S, Robinson DS, Varney V, et al. TNF alpha mRNA expression in allergic inflammation. Clin Exp Allergy. 1991;21:745-750.
3. Brightling C, Berry M, Amrani Y. Targeting TNF-alpha: a novel therapeutic approach for asthma. J Allergy Clin Immunol. 2008;121:5-10; quiz 11-12.
4. Berry MA, Hargadon B, Shelley M, et al. Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med. 2006;354:697-708. (Pubitemid 43247140)
5. Krutzik SR, Tan B, Li H, et al. TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nat Med. 2005;11:653-660. (Pubitemid 40868306)
6. Lambrecht BN, Hammad H. Biology of lung dendritic cells at the origin of asthma. Immunity. 2009;31:412-424.
7. Hsu SC, Chen CH, Tsai SH, et al. Functional interaction of common allergens and a C-type lectin receptor, dendritic cellYspecific ICAM3-grabbing non-integrin (DC-SIGN), on human dendritic cells. J Biol Chem. 2010;285:7903-7910.
8. Charbonnier AS, Hammad H, Gosset P, et al. Der p 1-pulsed myeloid and plasmacytoid dendritic cells from house dust miteYsensitized allergic patients dysregulate the T cell response. J Leukoc Biol. 2003;73:91-99. (Pubitemid 36125679)
9. Aronoff DM, Peres CM, Serezani CH, et al. Synthetic prostacyclin analogs differentially regulate macrophage function via distinct analog-receptor binding specificities. J Immunol. 2007;178: 1628-1634. (Pubitemid 46154634)
10. Idzko M, Hammad H, van Nimwegen M, et al. Inhaled iloprost suppresses the cardinal features of asthma via inhibition of airway dendritic cell function. J Clin Invest. 2007;117:464-472. (Pubitemid 46203975)
11. Hung CH, Chu YT, Suen JL, et al. Regulation of cytokine expression in human plasmacytoid dendritic cells by prostaglandin I2 analogues. Eur Respir J. 2009;33:405-410.
12. Kuo CH, Jan RL, Chu YT, et al. Prostaglandin I2 analogues enhance growth-related oncogene-> expression in human monocyte-derived dendritic cells. Inflammation. 2010;33:334-343.
13. Zhou W, Hashimoto K, Goleniewska K, et al. Prostaglandin I2 analogs inhibit proinflammatory cytokine production and T cell stimulatory function of dendritic cells. J Immunol. 2007;178:702-710. (Pubitemid 46095142)
14. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev. 1999;79: 1193-1226. (Pubitemid 29473315)
15. Mubarak KK. A review of prostaglandin analogs in the management of patients with pulmonary arterial hypertension. Respir Med. 2010;104:9-21.
16. Kapsenberg ML. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol. 2003;3:984-993. (Pubitemid 37521540)
17. Vincenti F. Costimulation blockade in autoimmunity and transplantation. J Allergy Clin Immunol. 2008;121:299-306; quiz 307-308. (Pubitemid 351215188)
18. Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol. 2002;2:151-161. (Pubitemid 37336516)
19. Bellinghausen I, Brand U, Knop J, et al. Comparison of allergen-stimulated dendritic cells from atopic and nonatopic donors dissecting their effect on autologous naive and memory T helper cells of such donors. J Allergy Clin Immunol. 2000;105:988-996. (Pubitemid 30324409)
20. Saeki S, Matsuse H, Kondo Y, et al. Effects of antiasthmatic agents on the functions of peripheral blood monocyteYderived dendritic cells from atopic patients. J Allergy Clin Immunol. 2004;114:538-544. (Pubitemid 39194926)
21. Michel O, Kips J, Duchateau J, et al. Severity of asthma is related to endotoxin in house dust. Am J Respir Crit Care Med. 1996;154:1641-1646. (Pubitemid 26424928)
22. Thorne PS, Kulhankova K, Yin M, et al. Endotoxin exposure is a risk factor for asthma: the national survey of endotoxin in United States housing. Am J Respir Crit Care Med. 2005;172:1371-1377. (Pubitemid 43069809)
23. Eisenbarth SC, Piggott DA, Huleatt JW, et al. Lipopolysaccharide- enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med. 2002;196: 1645-1651. (Pubitemid 36026476)
24. Wilson RH, Whitehead GS, Nakano H, et al. Allergic sensitization through the airway primes TH17-dependent neutrophilia and airway hyperresponsiveness. Am J Respir Crit Care Med. 2009;180:720-730.
25. Berry M, Brightling C, Pavord I, et al. TNF-alpha in asthma. Curr Opin Pharmacol. 2007;7:279-282.
26. Nagao K, Tanaka H, Komai M, et al. Role of prostaglandin I2 in airway remodeling induced by repeated allergen challenge in mice. Am J Respir Cell Mol Biol. 2003;29:314-320. (Pubitemid 37093989)
27. Wharton J, Davie N, Upton PD, et al. Prostacyclin analogues differentially inhibit growth of distal and proximal human pulmonary artery smooth muscle cells. Circulation. 2000;102:3130-3136.
28. Crutchley DJ, Solomon DE, Conanan LB. Prostacyclin analogues inhibit tissue factor expression in the human monocytic cell line THP-1 via a cyclic AMPYdependent mechanism. Arterioscler Thromb. 1992;12:664-670.
29. Kuo CH, Ko YC, Yang SN, et al. Effects of PGI(2) analogues on TH1- and TH2-related chemokines in monocytes via epigenetic regulation. J Mol Med. 2011;89:29-41.
30. Sallusto F, Cella M, Danieli C, et al. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med. 1995;182:389-400.
31. Huh JC, Strickland DH, Jahnsen FL, et al. Bidirectional interactions between antigen-bearing respiratory tract dendritic cells (DCs) and T cells precede the late phase reaction in experimental asthma: DC activation occurs in the airway mucosa but not in the lung parenchyma. J Exp Med. 2003;198:19-30. (Pubitemid 36870182)
32. Poulsen LK, Hummelshoj L. Triggers of IgE class switching and allergy development. Ann Med. 2007;39:440-456. (Pubitemid 47479265)
33. Suzuki M, Zheng X, Zhang X, et al. Inhibition of allergic responses by CD40 gene silencing. Allergy. 2009;64:387-397.
34. van Rijt LS, Vos N, Willart M, et al. Essential role of dendritic cell CD80/CD86 costimulation in the induction, but not reactivation, of TH2 effector responses in a mouse model of asthma. J Allergy Clin Immunol. 2004;114:166-173. (Pubitemid 39005134)
35. Agea E, Forenza N, Piattoni S, et al. Expression of B7 co-stimulatory molecules and CD1a antigen by alveolar macrophages in allergic bronchial asthma. Clin Exp Allergy. 1998;28:1359-1367. (Pubitemid 28559010)
36. Burastero SE, Magnani Z, Confetti C, et al. Increased expression of the CD80 accessory molecule by alveolar macrophages in asthmatic subjects and its functional involvement in allergen presentation to autologous TH2 lymphocytes. J Allergy Clin Immunol. 1999;103: 1136-1142. (Pubitemid 29343080)
37. Onishi RM, Gaffen SL. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology. 2010;129:311-321.
38. Schnyder-Candrian S, Togbe D, Couillin I, et al. Interleukin-17 is a negative regulator of established allergic asthma. J Exp Med. 2006;203:2715-2725. (Pubitemid 44833347)
39. Agache I, Ciobanu C, Agache C, et al. Increased serum IL-17 is an independent risk factor for severe asthma. Respir Med. 2010;104:1131-1137.
40. Jaffar Z, Ferrini ME, Buford MC, et al. Prostaglandin I2-IP signaling blocks allergic pulmonary inflammation by preventing recruitment of CD4+ TH2 cells into the airways in a mouse model of asthma. J Immunol. 2007;179:6193-6203.
41. Czeslick EG, Simm A, Grond S, et al. Inhibition of intracellular tumour necrosis factor (TNF)-alpha and interleukin (IL)-6 production in human monocytes by iloprost. Eur J Clin Invest. 2003;33:1013-1017. (Pubitemid 37421601)
42. Muller T, Durk T, Blumenthal B, et al. Iloprost has potent anti-inflammatory properties on human monocyte-derived dendritic cells. Clin Exp Allergy. 2010;40:1214-1221.